BlackRock, Inc. 13D and 13G filings for Editas Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
6,539,082 7.900% |
-1,299,887 (-16.58%) |
Filing |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
7,838,969 9.600% |
500,227 (+6.82%) |
Filing |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
7,338,742 10.700% |
0 (Unchanged) |
Filing |
| 2023-01-20 3:00 pm Purchase |
2022-12-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
7,338,742 10.700% |
355,967 (+5.10%) |
Filing |
| 2022-10-07 2:58 pm Purchase |
2022-09-30 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
6,982,775 10.200% |
1,549,399 (+28.52%) |
Filing |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
5,433,376 7.900% |
127,970 (+2.41%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Editas Medicine, Inc. EDIT |
BlackRock Inc. BLK |
5,305,406 8.500% |
1,064,208 (+25.09%) |
Filing |